The relationship between repetitive behaviors and growth hormone response to sumatriptan challenge in adult autistic disorder

Neuropsychopharmacology

Volumn 22, Issue 2, 2000, Pages 163-167

  Hollander, Eric ^a   Novotny, Sherie ^a   Allen, Andrea ^a   Aronowitz, Bonnie ^a   Cartwright, Charles ^a   DeCaria, Concetta ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Asperger's disorder; Autism; Growth hormone; Repetitive behavior; Serotonin; Sumatriptan

Indexed keywords

PLACEBO; SEROTONIN 1D AGONIST; SUMATRIPTAN;

ADULT; ANXIETY NEUROSIS; ARTICLE; ASPERGER SYNDROME; AUTISM; CLINICAL ARTICLE; CLINICAL TRIAL; COMPULSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GROWTH HORMONE RELEASE; HEADACHE; HUMAN; MALE; NAUSEA; PRIORITY JOURNAL; VERTIGO;

ADOLESCENT; ADULT; AUTISTIC DISORDER; COMPULSIVE BEHAVIOR; HUMAN GROWTH HORMONE; HUMANS; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RECEPTOR, SEROTONIN, 5-HT1D; RECEPTORS, SEROTONIN; REGRESSION ANALYSIS; SEROTONIN AGONISTS; SUMATRIPTAN;

EID: 0034141618     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(99)00121-9     Document Type: Article

References (26)

1. Adham N., Bard J.A., Zgombick J.M., Durkin M.M., Kucharewicz S., Weinshank R.L., Branchek T.A. Cloning and characterization of the guinea pig 5HT 1f receptor subtype. A comparison of the pharmacological profile to the human species homolog Neuropsychopharmacology. 36:1997;569-576.
2. Anderson G.M., Freedman D.X., Cohen D.S., Volkmar F.R., Hoder E.L., McPhederan P., Minderaa R.B., Hansen C.R., Young J.G. Whole blood serotonin in autistic and normal subjects. J Child Psychol Psychiatry. 28:1987;885-900.
3. Bard J.A., Kucharewicz S.A., Zgombik J.M., Weinshank R.L., Branchek T.A., Cohen M.L. Differences in ligand binding profiles between cloned rabbit and human 5HT 1d alpha and 5HT 1d beta receptors. Kentanserin and methiothepin distinguish rabbit 5HT 1d receptor subtypes Naunyn Schmeidebergs Arch Pharmacol. 354:1996;237-244.
4. Bolton P.F., Pickles A., Murphy M., Rutter M. Autism, affective and other psychiatric disorders. Patterns of familial aggregation Psychol Med. 28:1998;385-395.
5. Cook E.H., Charak D.A., Arida J., Spohn J.A., Roizen N.J.M., Leventhal B.L. Depressive and obsessive-compulsive symptoms in hyperserotonemic parents of children with autistic disorder. Psychiatric Res. 52:1994;25-33.
6. Cook E.H., Courchesne R., Lord C., Cox N.J., Yan S., Lincoln A., Haas R., Courchesne E., Leventhal B.L. Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry. 2:1997;247-250.
7. Chugani D.C., Muzik O., Rothermel R., Behen M., Chakraborty P., Mangner T., da Silva E.A., Chugani H.T. Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Ann Neurol. 42:1997;666-669.
8. Franceschini R., Cataldi A., Garibaldi P., Cianciosi P., Scordamaglia A., Barreca T., Rolandi E. The effects of sumatriptan on pituitary secretion in man. Neuropharmacology. 33:1994;235-239.
9. Gordon C.T., State R.C., Nelson J.E., Hamburger S.D., Rapoport J.L. A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Arch Gen Psychiatry. 50:1993;441-447.
10. Hollander E., Cartwright C., Wong C.M., DeCaria C.M., DelGiudice-Asch G., Buchsbaum M.S., Aronowitz B. A dimensional approach to the autism spectrum. CNS Spectrums: Intl J Neuropsych Med. 3:1998;22-39.
11. Hollander E., DelGiudice-Asch G., Simon L., Schmeidler J., Cartwright C., DeCaria C., Kwon J., Cunningham-Rundles C., Chapman F., Zabriskie J. B-lymphocyte antigen D8/17 and repetitive behaviors in autism. Am J Psychiatry. 156:1999;317-320.
12. Hoshino Y., Yamamoto T., Kaneko M., Tachibana R., Watanabe M., Ono Y., Kumashiro H. Blood serotonin and free tryptophan concentration in autistic children. Neuropsychobiology. 11:1984;22-27.
13. Klauck S.M., Poustka F., Brenner A., Lesch K.P., Poustka A. Serotonin transporter (5HTT) gene variants associated with autism? Human Mol Genet. 6(13):1997;2233-2238.
14. Leboyer M., Philippe A., Bouvard M., Guilloud-Bataille M., Bondoux D., Tabuteau F., Feingold J., Mouren-Simeoni M.C., Launay J.M. Whole blood serotonin and plasma beta-endorphin in autistic probands and their first degree relatives. Biol Psychiatry. 45:1999;158-163.
15. Lord C., Rutter M., LeCouteur A. Autism Diagnostic Interview - Revised. A revised version of a diagnostic scale for caregivers of individuals with possible pervasive developmental disorders J Autistic Devel Dis. 24(5):1994;659-685.
16. McBride P.A., Anderson G.M., Hertzig M.E., Sweeny J.A., Kream J., Cohen D.J., Mann J.J. Serotonergic responsivity in male young adults with autistic disorder. Results of a pilot study. Arch Gen Psychiatry. 46:1989;213-221.
17. McDougle C.J., Naylor S.T., Cohen D.J., Aghajanian G.K., Henninger G.R., Price L.H. Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry. 53:1996;993-1000. a.
18. McDougle C.J., Naylor S.T., Cohen D.J., Volkmar F.R., Heninger G.R., Price L.H. A double-blind, placebo controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry. 53:1996;1001-1008. b.
19. Mehlinger R., Scheftner W.A., Pozanski E. Fluoxetine and autism. J Am Acad Child Adolesc Psychiatry. 29:1990;985.
20. Mota A., Bento A., Peñalva A., Pombo M., Dieguez C. Role of serotonin receptor subtype 5-HT 1d on basal and stimulated growth hormone secretion. J Clin Endocrinol Metab. 80:1995;1973-1977.
21. Novotny S., Hollander E., Allen A., Mosovich S., Aronowitz B., Cartwright C., DeCaria C. Increased growth hormone response to sumatriptan challenge in adult autistic disorders. Psychiatric Res. in press:1999.
22. Pascual J., del Arco C., Romon T., del Olmo E., Castro E., Pazos A. Autoradiographic distribution of [3H] sumatriptan-binding sites in post-mortem human brain. Cephalalagia. 16(5):1996;317-322.
23. Peroutka S.J., McCarthy B.G. Sumatriptan (GR 43175) interacts selectively with 5-HT1B and 5-HT1D binding sites. Eur J Pharmacol. 163:1989;133-136.
24. Piven J., Tsai G., Nenme E., Coyle J.T., Folstein S.E. Platelet serotonin, a possible marker for familial autism. J Autism Der Disord. 21:1991;51-59.
25. Steingard R.J., Ziminitzky B., DeMaso D.R., Bauman M.L., Bucci J.P. Sertraline treatment of transition-associated anxiety and agitation in children with autistic disorder. J Am Acad Child Adolesc Psychiatry. 7:1997;9-15.
26. Yatham L.N., Lam R.W., Zis A.P. Growth hormone response to sumatriptan (5-HT1d agonist) challenge in seasonal affective disorder. Effects of light therapy Biol Psychiatry. 42:1997;24-29.